Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Clinical trial NCT03474640 · COMPLETED
Trial details
- NCT number
- NCT03474640
- Sponsor
- TopAlliance Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2022-06-07
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.